Literature DB >> 21396893

Blood vessel tubulogenesis requires Rasip1 regulation of GTPase signaling.

Ke Xu1, Anastasia Sacharidou, Stephen Fu, Diana C Chong, Brian Skaug, Zhijian J Chen, George E Davis, Ondine Cleaver.   

Abstract

Cardiovascular function depends on patent blood vessel formation by endothelial cells (ECs). However, the mechanisms underlying vascular "tubulogenesis" are only beginning to be unraveled. We show that endothelial tubulogenesis requires the Ras interacting protein 1, Rasip1, and its binding partner, the RhoGAP Arhgap29. Mice lacking Rasip1 fail to form patent lumens in all blood vessels, including the early endocardial tube. Rasipl null angioblasts fail to properly localize the polarity determinant Par3 and display defective cell polarity, resulting in mislocalized junctional complexes and loss of adhesion to extracellular matrix (ECM). Similarly, depletion of either Rasip1 or Arhgap29 in cultured ECs blocks in vitro lumen formation, fundamentally alters the cytoskeleton, and reduces integrin-dependent adhesion to ECM. These defects result from increased RhoA/ROCK/myosin II activity and blockade of Cdc42 and Rac1 signaling. This study identifies Rasip1 as a unique, endothelial-specific regulator of Rho GTPase signaling, which is essential for blood vessel morphogenesis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396893      PMCID: PMC3078994          DOI: 10.1016/j.devcel.2011.02.010

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  59 in total

1.  Vascular lumen formation from a cell biological perspective.

Authors:  Tomás Kucera; Jan Eglinger; Boris Strilić; Eckhard Lammert
Journal:  Novartis Found Symp       Date:  2007

Review 2.  Cellular and molecular mechanisms of vascular lumen formation.

Authors:  M Luisa Iruela-Arispe; George E Davis
Journal:  Dev Cell       Date:  2009-02       Impact factor: 12.270

3.  Cell-autonomous requirement for beta1 integrin in endothelial cell adhesion, migration and survival during angiogenesis in mice.

Authors:  Timothy R Carlson; Huiqing Hu; Rickmer Braren; Yung Hae Kim; Rong A Wang
Journal:  Development       Date:  2008-05-14       Impact factor: 6.868

Review 4.  Morphogenesis of epithelial tubes: Insights into tube formation, elongation, and elaboration.

Authors:  Deborah J Andrew; Andrew J Ewald
Journal:  Dev Biol       Date:  2009-09-22       Impact factor: 3.582

5.  Biphasic Ngn3 expression in the developing pancreas.

Authors:  Alethia Villasenor; Diana C Chong; Ondine Cleaver
Journal:  Dev Dyn       Date:  2008-11       Impact factor: 3.780

6.  Cdc42- and Rac1-mediated endothelial lumen formation requires Pak2, Pak4 and Par3, and PKC-dependent signaling.

Authors:  Wonshill Koh; Rachel D Mahan; George E Davis
Journal:  J Cell Sci       Date:  2008-03-04       Impact factor: 5.285

Review 7.  Modes of resistance to anti-angiogenic therapy.

Authors:  Gabriele Bergers; Douglas Hanahan
Journal:  Nat Rev Cancer       Date:  2008-08       Impact factor: 60.716

8.  Beta1 integrin expression on endothelial cells is required for angiogenesis but not for vasculogenesis.

Authors:  Harikrishna Tanjore; Elisabeth M Zeisberg; Behzad Gerami-Naini; Raghu Kalluri
Journal:  Dev Dyn       Date:  2008-01       Impact factor: 3.780

Review 9.  The emerging role of anti-angiogenic therapy for malignant glioma.

Authors:  David A Reardon; Annick Desjardins; Jeremy N Rich; James J Vredenburgh
Journal:  Curr Treat Options Oncol       Date:  2008-02-07

10.  Cdc42 controls spindle orientation to position the apical surface during epithelial morphogenesis.

Authors:  Aron B Jaffe; Noriko Kaji; Joanne Durgan; Alan Hall
Journal:  J Cell Biol       Date:  2008-11-10       Impact factor: 10.539

View more
  79 in total

1.  Integration of repulsive guidance cues generates avascular zones that shape mammalian blood vessels.

Authors:  Stryder M Meadows; Peter J Fletcher; Carlos Moran; Ke Xu; Gera Neufeld; Sophie Chauvet; Fanny Mann; Paul A Krieg; Ondine Cleaver
Journal:  Circ Res       Date:  2011-11-10       Impact factor: 17.367

Review 2.  Recent advances in vascular development.

Authors:  Courtney K Domigan; M Luisa Iruela-Arispe
Journal:  Curr Opin Hematol       Date:  2012-05       Impact factor: 3.284

Review 3.  Integration of experimental and computational approaches to sprouting angiogenesis.

Authors:  Shayn M Peirce; Feilim Mac Gabhann; Victoria L Bautch
Journal:  Curr Opin Hematol       Date:  2012-05       Impact factor: 3.284

4.  Cardioproteomics: advancing the discovery of signaling mechanisms involved in cardiovascular diseases.

Authors:  Ziyou Cui; Shannamar Dewey; Aldrin V Gomes
Journal:  Am J Cardiovasc Dis       Date:  2011-09-10

Review 5.  Molecular mechanisms controlling vascular lumen formation in three-dimensional extracellular matrices.

Authors:  Anastasia Sacharidou; Amber N Stratman; George E Davis
Journal:  Cells Tissues Organs       Date:  2011-10-13       Impact factor: 2.481

Review 6.  Apicobasal polarity of brain endothelial cells.

Authors:  Thomas Worzfeld; Markus Schwaninger
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-06       Impact factor: 6.200

7.  Elevated endothelial Sox2 causes lumen disruption and cerebral arteriovenous malformations.

Authors:  Jiayi Yao; Xiuju Wu; Daoqin Zhang; Lumin Wang; Li Zhang; Eric X Reynolds; Carlos Hernandez; Kristina I Boström; Yucheng Yao
Journal:  J Clin Invest       Date:  2019-06-24       Impact factor: 14.808

Review 8.  Tubulogenesis.

Authors:  M Luisa Iruela-Arispe; Greg J Beitel
Journal:  Development       Date:  2013-07       Impact factor: 6.868

Review 9.  Cellular and molecular mechanisms underlying blood vessel lumen formation.

Authors:  Marta S Charpentier; Frank L Conlon
Journal:  Bioessays       Date:  2013-12-09       Impact factor: 4.345

10.  Pharmacological manipulation of blood and lymphatic vascularization in ex vivo-cultured mouse embryos.

Authors:  Martin Zeeb; Jennifer Axnick; Lara Planas-Paz; Thorsten Hartmann; Boris Strilic; Eckhard Lammert
Journal:  Nat Protoc       Date:  2012-10-11       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.